Trial intelligence / Profile preview

Metformin Effect on Neuregulin-4 in Children with Type 1 Diabetes

NCT04879511Phase 3Completed

Sponsor
Ain Shams University
Start
Feb 2018
Primary completion
Jan 2021
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of liquid metformin (Aspargo Labs) in type 1 diabetes mellitus (T1D), sponsored by Ain Shams University. Started Feb 2018; status: completed.

02

Drugs

liquid metformin (Aspargo Labs)
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT04879511.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04879511.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call